0001209191-19-006627.txt : 20190201 0001209191-19-006627.hdr.sgml : 20190201 20190201202412 ACCESSION NUMBER: 0001209191-19-006627 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190130 FILED AS OF DATE: 20190201 DATE AS OF CHANGE: 20190201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Mahatme Sandesh CENTRAL INDEX KEY: 0001511034 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-14895 FILM NUMBER: 19561413 MAIL ADDRESS: STREET 1: C/O CELGENE CORPORATION STREET 2: 86 MORRIS AVENUE CITY: SUMMIT STATE: NJ ZIP: 07901 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sarepta Therapeutics, Inc. CENTRAL INDEX KEY: 0000873303 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 930797222 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-274-4000 MAIL ADDRESS: STREET 1: 215 FIRST STREET STREET 2: SUITE 415 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Sarepta Therapuetics, Inc. DATE OF NAME CHANGE: 20120712 FORMER COMPANY: FORMER CONFORMED NAME: AVI BIOPHARMA INC DATE OF NAME CHANGE: 19980930 FORMER COMPANY: FORMER CONFORMED NAME: ANTIVIRALS INC DATE OF NAME CHANGE: 19970123 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2019-01-30 0 0000873303 Sarepta Therapeutics, Inc. SRPT 0001511034 Mahatme Sandesh 215 FIRST STREET, SUITE 415 CAMBRIDGE MA 02142 0 1 0 0 EVP, CFO & CBO Common Stock 2019-01-30 4 M 0 5469 13.71 A 14118 D Common Stock 2019-01-30 4 M 0 1128 13.71 A 15246 D Common Stock 2019-01-30 4 M 0 17860 13.90 A 33106 D Common Stock 2019-01-30 4 M 0 19345 23.85 A 52451 D Common Stock 2019-01-30 4 S 0 43802 130.00 D 8649 D Common Stock 2019-01-31 4 M 0 21198 23.85 A 29847 D Common Stock 2019-01-31 4 S 0 21198 130.72 D 8649 D Common Stock 12012 I By trust Stock Option (right to buy) 13.71 2019-01-30 4 M 0 5469 0.00 D 2017-02-28 2026-02-28 Common Stock 5469 7404 D Stock Option (right to buy) 13.71 2019-01-30 4 M 0 1128 0.00 D 2017-02-28 2026-02-28 Common Stock 1128 6771 D Stock Option (right to buy) 13.90 2019-01-30 4 M 0 17860 0.00 D 2016-02-27 2025-02-27 Common Stock 17860 0 D Stock Option (right to buy) 23.85 2019-01-30 4 M 0 19345 0.00 D 2013-11-05 2022-11-05 Common Stock 19345 96664 D Stock Option (right to buy) 23.85 2019-01-31 4 M 0 21198 0.00 D 2013-11-05 2022-11-05 Common Stock 21198 75466 D This transaction was effected pursuant to a Rule 10b5-1 Plan. Accordingly, the reporting person had no discretion with regards to the timing of the transaction. /s/ David Tyronne Howton, as attorney-in-fact for Sandesh Mahatme 2019-02-01